Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioCryst Pharmaceuticals Inc BCRX

Healthcare Biotechnology
BioCryst Pharmaceuticals, Inc. is a biotechnology company focused on improving the lives of people living with complement-mediated and other rare diseases. The Company leverages its expertise in designing to develop first-in-class oral small-molecule and protein therapeutics to target difficult-to-treat diseases. Its marketed products include oral, once-daily ORLADEYO for the prevention of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BCRX)

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 4, 2024

BioCryst Launches ORLADEYO® (berotralstat) in Ireland

GlobeNewswire November 18, 2024

BioCryst to Present at Upcoming Investor Conferences

GlobeNewswire November 6, 2024

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire November 5, 2024

BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire November 4, 2024

BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat)

GlobeNewswire October 24, 2024

BioCryst to Report Third Quarter 2024 Financial Results on November 4

GlobeNewswire October 21, 2024

BioCryst to Present New Real-World Evidence Showing Significant Reductions in Medical Visits and Hospitalizations After Starting ORLADEYO® (berotralstat)

GlobeNewswire October 14, 2024

BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting

GlobeNewswire October 10, 2024
View More News ››

Opinion & Analysis (NDAQ:BCRX)

The Calandra Report: Blood in streets, rivers of fortune

Thom Calandra July 24, 2015

The Calandra Report: Rapivab, MERS, Thailand & BCRX

Thom Calandra June 19, 2015

The Calandra Report: Show me a favorite, I dare you

Thom Calandra June 8, 2015

The Calandra Report: Moveable feast of pharma, not gold

Thom Calandra June 4, 2015

The Calandra Report: They're jamming In the name of the lode

Thom Calandra March 13, 2015

Ultra-Actionables: Natcore Tech, Angkor Gold, BioCryst, Vegas

Thom Calandra February 20, 2015
View More Opinion ››

Bullboard Posts (NDAQ:BCRX)

BioCryst Reports Third Quarter 2024 Financial Results and Pr

NEWS: $BCRX BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update@ Q3 2024 ORLADEYO net revenue of $116.3...
whytestocks - November 4, 2024

BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Ou

JUST IN: $BCRX BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance | BenzingaMonday...
whytestocks - May 6, 2024

BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estim

Just In: $BCRX BioCryst Pharmaceuticals Reports Q1 Loss, Tops Revenue Estimates | BenzingaBioCryst Pharmaceuticals (NASDAQ: BCRX) came...
whytestocks - May 6, 2024

4 PROMISING BIOTECH STOCKS WITH IMMENSE POTENTIAL!

$BCRX $IPSC $DYAI $CDNA   Clinical-Stage companies offer an exciting investment opportunity with massive upside potential. Most of...
AviseAnalytics - January 14, 2022

BCRX LONG!

My largest holding   Awaiting Factor D news Mar 22.  This can be life changing.   
mevani - March 17, 2021

BOOM!!!!! eom

Now we are getting noticed.  Still holding my shares.
mevani - February 1, 2021
View more Bullboard ››

TAG Oil Ltd.

TAG Oil Ltd.

TAG Oil Ltd. is an international oil and gas exploration company with a focus on operations and opportunities in the Middle ...
View More »